Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement
NCT02777541 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2016-05-20
Summary
There aren't sufficient randomized prospective controlled trials in pediatric population comparing the safety and tolerance of early feeding after PEG placement (3-4 hours). Most patients are fasted for at least 12 hours following percutaneous endoscopic gastrostomy. In order to decrease the period of fasting, inadequate nutritional support, and hospitalization time, the investigators decided to design this study. The additional goal is to establish an optimum standard procedure in the group of pediatric patients qualified for PEG insertion procedure in Poland.
Conditions
- Enteral Nutritional Support
Interventions
- DIETARY_SUPPLEMENT
-
Resumption of feeding 3 hours after PEG placement
The first feeding will be with polymeric diet (1 kcal/ml). First feeding portion will have the volume equal to 1/3 of full recommended portion, volume of second feeding will be equal to 2/3 of full recommended portion and third portion will be equal to full recommended portion. Each portion will introduced thru the enteral feeding pump (Flocare Infinity, Nutricia), for 30 minutes, three-hour break between feeds. Infusion of 5% glucose solution with electrolytes will be given through intravenous line to cover maintenance fluid requirement in all subjects.
- DIETARY_SUPPLEMENT
-
Resumption of feeding 8 hours after PEG placement
The first feeding will be with polymeric diet (1 kcal/ml). First feeding portion will have the volume equal to 1/3 of full recommended portion, volume of second feeding will be equal to 2/3 of full recommended portion and third portion will be equal to full recommended portion. Each portion will introduced thru the enteral feeding pump (Flocare Infinity, Nutricia), for 30 minutes, three-hour break between feeds. Infusion of 5% glucose solution with electrolytes will be given through intravenous line to cover maintenance fluid requirement in all subjects.
Sponsors & Collaborators
-
Nutricia Foundation
collaborator OTHER -
Children's Memorial Health Institute, Poland
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-12-31
Countries
- Poland
Study Locations
More Related Trials
-
Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology
NCT04900597 ·Status: RECRUITING ·Phase: NA
-
Nocturnal Cyclic Enteral Nutrition Infusion Versus Continuous Infusion of Enteral Nutrition
NCT03727165 ·Status: WITHDRAWN ·Phase: NA
-
TubeClear® Evaluation in Pediatric Patients (Phase I)
NCT02724631 ·Status: TERMINATED ·Phase: NA
-
Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis
NCT03123809 ·Status: COMPLETED ·Phase: NA
-
Reducing Fasting Time in Children for Sedation
NCT05757882 ·Status: COMPLETED ·Phase: NA
-
Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis
NCT02164591 ·Status: TERMINATED
-
Safety During Use of Paediatric Triple Chamber Bag Formulas
NCT01304394 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
NCT04733066 ·Status: UNKNOWN
-
Enteral Glutamine Supplementation for the Patient With Major Torso Trauma
NCT00178581 ·Status: TERMINATED ·Phase: PHASE1
-
Initial Parenteral Nutrition Education of Parent Assessment Plan
NCT04816734 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
NCT03571516 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications
NCT03953170 ·Status: WITHDRAWN ·Phase: PHASE3
-
Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation
NCT02290626 ·Status: WITHDRAWN ·Phase: NA
-
Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
NCT00432835 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study to Evaluate Safety of Nutriseal™ Nutriplace™ System
NCT03371160 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT
NCT02338440 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intermittent Oro-Esophageal Tube Feeding vs. Nasogastric Tube Feeding in Infants With Pierre Robin Syndrome
NCT06178562 ·Status: TERMINATED ·Phase: NA
-
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
NCT00595621 ·Status: COMPLETED ·Phase: NA
-
Is Electrolyte Maintenance Solution Required in Low-Risk Children With Gastroenteritis?
NCT01185054 ·Status: COMPLETED ·Phase: PHASE2
-
Removal of Nasogastric Feeding Tube Post Extubation in ICU : a Prospective Randomized Trial
NCT05795569 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
NCT00081458 ·Status: COMPLETED ·Phase: PHASE3
-
LASER THERAPY IN GASTRIC STOMA INJURIES OF CHILDREN AND ADOLESCENTS
NCT04863196 ·Status: UNKNOWN ·Phase: NA
-
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381 ·Status: COMPLETED ·Phase: PHASE3
-
Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
NCT02007759 ·Status: TERMINATED ·Phase: NA
-
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
NCT01075789 ·Status: TERMINATED ·Phase: NA